Physiologically-based pharmacokinetic modeling for predicting drug-drug interactions induced by acid-reducing agents
Xiao-wen WANG; Qing-feng HE; Xiao-qiang XIANG; Bing HAN.
Acta Pharmaceutica Sinica
; (12): 2197-2203, 2021.
ArtÃculo en Zh | WPRIM | ID: wpr-887046
Documentos relacionados
Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid-Reducing Agents.
Onset of acid-neutralizing action of a calcium/magnesium carbonate-based antacid using an artificial stomach model: an in vitro evaluation.
Drug interactions between HIV protease inhibitors and acid-reducing agents.
Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents.
Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.
Use of food and food-derived products in the treatment of gastritis: A systematic review.
Concomitant use of capecitabine and proton pump inhibitors - Is it safe?
Impact of Acid-Reducing Agents on Gastrointestinal Physiology and Design of Biorelevant Dissolution Tests to Reflect These Changes.
[Effects of Oral Magnesium and Antacid Administration on Serum Magnesium Levels and Renal Function in Patients Receiving Cisplatin].
Potential or contraindicated drug-drug interactions with antiretroviral therapy in real-world settings in Taiwan.